Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cell Therapy Market Grown from 2024 to 2025?

The market size for cell therapy has seen swift expansion in the past few years. It is set to escalate from $14.56 billion in 2024 to $17.02 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.9%. The growth observed in the historic period is a result of initial research and discoveries, regulatory achievements, clinical trials and studies, early adopters, as well as innovative companies, and the overall market acceptance and perception.

What Growth Rate Is Anticipated for the Cell Therapy Market in the Coming Years?

The market size of cell therapy is foreseen to experience a significant surge in the coming years, expanding to $29.28 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.5%. The projected growth during this period is influenced by several factors, such as ethical and societal issues, investment trends, funding approaches, demands of patients/consumers, the health care infrastructure, and fast-paced innovation. The upcoming trends within this phase will be personalized medicine, development of targeted therapies, advancement in gene editing technologies, expansion of stem cell research, improvements in immunotherapy, and microenvironment manipulation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Who Are the Leading Companies in the Cell Therapy Market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

What Are the Key Drivers of the Cell Therapy Market?

The escalating incidences of chronic illnesses have propelled the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines a chronic disease as a condition that persists for a year or longer necessitating medical care, inhibits daily activities, or both; this includes ailments like heart disease, cancer, diabetes, and Parkinson’s. Stem cells offer significant benefits to patients who suffer from conditions such as spinal cord injury, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. In July 2024, the CDC, a US-based national public health agency, released substantial updates related to public health strategies. Annually, heart disease or stroke strikes down over 944,800 Americans, constituting over a third of all deaths. In the US, cancer is diagnosed in 1.7 million people annually, resulting in over 600,000 deaths, emerging as the second most frequent cause of death. Additionally, over 38 million Americans are living with diabetes, while another 98 million adults are prediabetic, at a heightened risk of developing type 2 diabetes. Diabetes can result in grave complications including heart disease, kidney failure, and blindness. Obesity, affecting 20% of children and 42% of adults, exacerbates the risk of chronic diseases such as type 2 diabetes, heart disease, and specific cancers. Consequently, the escalating incidence of chronic diseases has spurred the demand for cell therapies, fueling the expansion of the cell therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

What Are the Key Market Segments in the Cell Therapy Industry?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Are the Latest Trends in the Cell Therapy Market?

Critical players in the market are tactically forming alliances and collaborations to broaden their product range and deepen their global footprint. Ajinomoto Co Inc., a food corporation from Japan, purchased Forge Biologics for $620 million in November 2023. This move was designed to enhance Ajinomoto Co Inc.’s worldwide prowess in AAV and plasmid gene therapy production, thus strengthening its current contract development and manufacturing services. Forge Biologics, situated in the United States, is a biotech firm committed to furthering cell therapy technologies for treating numerous illnesses.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Are the Key Regional Markets in the Cell Therapy Industry?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

This Report Delivers Insight On:

1. How big is the cell therapy market, and how is it changing globally?

2. Who are the major companies in the cell therapy market, and how are they performing?

3. What are the key opportunities and risks in the cell therapy market right now?

4. Which products or customer segments are growing the most in the cell therapy market?

5. What factors are helping or slowing down the growth of the cell therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model